Related Experiment Video
Updated: Dec 14, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Ferroptosis in Liver Diseases: An Overview
Martina Maria Capelletti1,2, Hana Manceau1,3, Hervé Puy1,4
1Centre de Recherche sur l'Inflammation, INSERM U1149, Université de Paris, Laboratory of Excellence GR-Ex, 75018 Paris, France.
Ferroptosis, a cell death form, involves iron and lipid peroxides. This review details ferroptosis mechanisms, its role in liver diseases, and its therapeutic potential for liver cancer.
Area of Science:
- Biochemistry
- Cell Biology
- Pathology
Background:
- Ferroptosis is a distinct iron-dependent cell death pathway.
- It is characterized by lipid peroxide accumulation and redox imbalance.
- Key features include GPX4 inactivation and PUFA oxidation.
Purpose of the Study:
- To comprehensively analyze ferroptosis mechanisms.
- To review ferroptosis inducers and inhibitors.
- To discuss ferroptosis's role in liver diseases and cancer therapy.
Main Methods:
- Literature review of ferroptosis mechanisms.
- Analysis of pathways influencing ferroptosis.
- Examination of ferroptosis's involvement in hepatic disorders.
Main Results:
- Ferroptosis is regulated by iron metabolism, GPX4, and phospholipid pathways.
- It is implicated in acute kidney injury, cancer, and liver diseases.
- Therapeutic strategies targeting ferroptosis are emerging.
Conclusions:
- Ferroptosis is a critical cell death mechanism with broad pathological relevance.
- Understanding ferroptosis offers new avenues for treating liver diseases.
- Targeting ferroptosis shows promise for hepatocellular carcinoma treatment.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...

